Home › Funds › EQUITEC PROPRIETARY MARKETS, LLC › PMCB

EQUITEC PROPRIETARY MARKETS, LLC position in PMCB

PHARMACYTE BIOTECH INC · Health Care

EQUITEC PROPRIETARY MARKETS, LLC reported holding 22,227 shares of PMCB (PHARMACYTE BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$9K, representing 0.01% of its reported portfolio and ranking #35 among its reported holdings. EQUITEC PROPRIETARY MARKETS, LLC has disclosed PMCB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)22.23K sh
Reported value held$9.13K
Portfolio Weight0.01%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EQUITEC PROPRIETARY MARKETS, LLC's PMCB position evolved

EQUITEC PROPRIETARY MARKETS, LLC first disclosed a stake in PMCB in Q3 2023 at 82,727 shares (US$174K). The position peaked in Q1 2024 at 82,727 shares, worth US$196K. Across 13 filings, EQUITEC PROPRIETARY MARKETS, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 22,227 shares valued at US$9K. Notable position changes include a 73% trim in Q4 2025 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 82.73K $173.73K New
Q4 2023 82.73K $178.69K Hold
Q1 2024 82.73K $196.06K Hold
Q2 2024 82.73K $162.15K Hold
Q3 2024 82.73K $158.01K Hold
Q4 2024 82.73K $129.88K Hold
Q1 2025 82.73K $103.41K Hold
Q2 2025 82.73K $90.17K Hold
Q3 2025 82.73K $80.21K Hold
Q4 2025 22.23K $16.09K Reduce
Q1 2026 22.23K $14.79K Hold
Q2 2026 22.23K $17.11K Hold
Q3 2026 22.23K $9.13K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PMCB and 13F data

PMCB (PHARMACYTE BIOTECH INC) is a Health Care company. 21 other funds we track also report a position in PMCB. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PMCB

No other tracked fund reports a position in PMCB.

All PMCB fund holders →

FAQ

How long has EQUITEC PROPRIETARY MARKETS, LLC held PMCB?

EQUITEC PROPRIETARY MARKETS, LLC has disclosed PMCB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EQUITEC PROPRIETARY MARKETS, LLC's current position in PMCB?

As of Q3 2026, EQUITEC PROPRIETARY MARKETS, LLC holds 22.23K shares of PMCB (PHARMACYTE BIOTECH INC), valued at $9.13K, representing 0.01% of its reported portfolio and ranking #35.

Has EQUITEC PROPRIETARY MARKETS, LLC been buying or selling PMCB?

In the latest 13F filing (Q3 2026), EQUITEC PROPRIETARY MARKETS, LLC held unchanged its position in PMCB. The position peaked in Q1 2024 at 82.73K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.